Login

Lyka Labs Ltd.

₹100.25

Overview Charts Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Corp. Action Documents
Consolidated
Standalone

Lyka Labs Ltd.

  • NSE : LYKALABS
Add Alert
Add Watchlist

₹100.25

₹100.25

0.74 (0.74%) - 18 Aug 2025 04:27 PM
  • NSE : LYKALABS

About Company

Lyka Labs Limited (Lyka) is an India-based healthcare company. The Company is manufacture of lyophilized products. The primary segment of the Company is business segment, which consists of pharmaceutical products /pharma related services. The Company’s Lyophilization facility is at Ankleshwar. The Company’s prospects of lyophilized products are in both formulations and Bulk Drugs, which have presence in domestic and international markets.

Market Cap. ₹ 358 Cr.
52 Week - High/Low ₹ 177/97
P/E Ratio 49.14
P/B Ratio 2.65
Enterprise Value ₹ 382 Cr.
ROE % 7.31
RSI Value 28.13
EMA 50 110.7
EMA 200 119.84
Market Cap. ₹ 358 Cr.
52 Week - High/Low ₹ 177/97
P/E Ratio 47.51
P/B Ratio 3.46
Enterprise Value ₹ 382 Cr.
ROE % 9.76
RSI Value 28.13
EMA 50 110.7
EMA 200 119.84
Add Parameters

Growth

Chart Icon
View Full Chart

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Terms | Privacy | Contact Us
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.